General form of registration statement for all companies including face-amount certificate companies

INCOME (LOSS) PER SHARE / EARNINGS PER SHARE (Tables)

v3.21.2
INCOME (LOSS) PER SHARE / EARNINGS PER SHARE (Tables)
6 Months Ended 12 Months Ended
May 31, 2021
Nov. 30, 2020
Earnings Per Share [Abstract]    
Schedule of anti-dilutive shares

Preferred Stock, warrants, stock options, and RSUs that could potentially dilute basic EPS in the future that were not included in the computation of diluted loss per share were as follows:

 

    For the Three Months Ended
May 31, 2020
    For the Six Months Ended
May 31, 2020
 
Series A Preferred Stock     4,636,667       4,636,667  
Warrants     2,783,702       2,783,702  
Stock Options     672,667       672,667  
RSUs            
Total     8,093,036       8,093,036  

 

The following were excluded from the calculation of diluted net income per share for the three and six months ended May 31, 2021 because their effects are anti-dilutive:

 

    For the Three Months Ended May 31, 2021   For the Six Months Ended May 31, 2021
Antidilutive securities:                
Options     638,000       518,000  
RSUs     50,000       68,493  
Total antidilutive securities     688,000       586,493  

 

The following potential common shares, presented based on amounts outstanding at each period end, were excluded from the calculation of diluted net loss per share attributable to common stockholders for the periods indicated because including them would have had an anti-dilutive effect:

 

    November 30,  
    2020     2019  
Series A Preferred Stock     46,366,490        
Warrants     5,857,386       45,787,219  
Stock Options     7,059,667       2,911,667  
Restricted Stock     15,735,000        
Total     75,018,543       48,698,886  
Schedule of allocation of net income (loss)

The following table sets forth the allocation of net income (loss) for the three and six months ended May 31, 2021 and 2020, respectively:

    For the Three Months Ended
May 31,
  For the Six Months Ended
May 31,
    2021   2020   2021   2020
Net income (loss)   $ 2,037     $ (8,061 )   $ 1,765     $ (10,346 )
Net income applicable to preferred stock     (1,043 )     —         (1,043 )     —    
Income available to common shareholders   $ 994     $ (8,061 )   $ 722     $ (10,346 )
 
Schedule of weighted-average common shares outstanding used in the calculation of basic and diluted EPS

The following table reconciles the weighted-average common shares outstanding used in the calculation of basic EPS to the weighted-average common shares outstanding used in the calculation of diluted EPS for the three and six months ended May 31, 2021 and 2020:

 

    For the Three Months Ended
May 31,
    For the Six Months Ended
May 31,
 
    2021     2020     2021     2020  
Weighted-average common shares outstanding- basic     17,800,749       12,068,759       16,359,496       11,271,719  
Assumed conversion of:                                
Dilutive Stock Options     597,214             600,918        
Dilutive Warrants     304,883             399,332        
Dilutive RSUs     286,385             244,385        
Weighted-average common share outstanding- diluted     18,989,231       12,068,759       17,604,131       11,271,719